Roche’s Top-Selling Drug’s New High-Dose Version Fails in Study
Roche Holding AG said a high-dose version of Ocrevus, its best-selling multiple sclerosis drug, failed to outperform the ...
Why Is Pharma Giant Roche Stock Trading Lower On Wednesday?
Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...
Indiatimes18h
Suven Life Sciences Share Price
Suven Life Sciences Ltd., incorporated in the year 1989, is a Mid Cap company (having a market cap of Rs 2,743.59 Crore) operating in Pharmaceuticals sector. Suven Life Sciences Ltd. key ...
hdbuzz.net15h
Dr Sarah Hernandez
Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...